Physician profile
Danielle Monteiro
NPI 1578174009
$667.41
in general payments reported to CMS, 2019-2025
16 companies · $24.04 in 2025
The $24.04 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.10 · 2022: $268 · 2023: $209 · 2024: $81.15 · 2025: $24.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $119.68 | 2022-2023 | Seglentis, Livalo |
| Novo Nordisk INC | $100.46 | 2022-2023 | Saxenda |
| Abbvie INC. | $97.87 | 2021-2023 | |
| Genzyme Corporation | $65.55 | 2024 | |
| Boston Scientific Corporation | $44.26 | 2021-2023 | |
| Exact Sciences Corporation | $44.21 | 2023 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $43.76 | 2022 | |
| Sanofi-Aventis U.S. LLC | $29.37 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $24.04 | 2025 | Neffy |
| Genentech USA, INC. | $15.60 | 2024 | Xolair |
| Sanofi Pasteur INC. | $14.67 | 2022 | |
| Mayne Pharma Commercial LLC | $14.33 | 2022 | |
| Depuy Synthes Sales INC. | $13.95 | 2023 | Orthovisc |
| Teva Pharmaceuticals USA, INC. | $13.81 | 2023 | Austedo |
| Ferring Pharmaceuticals INC. | $13.12 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $12.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Monteiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.